The potential of liquid biopsy in the management of cancer patients
A Markou, E Tzanikou, E Lianidou - Seminars in cancer biology, 2022 - Elsevier
Over the last decade, liquid biopsy has gained much attention as a powerful tool in
personalized medicine, since it enables monitoring cancer evolution and follow-up of cancer …
personalized medicine, since it enables monitoring cancer evolution and follow-up of cancer …
Clinical applications of the CellSearch platform in cancer patients
S Riethdorf, L O'Flaherty, C Hille, K Pantel - Advanced drug delivery …, 2018 - Elsevier
Abstract The CellSearch® system (CS) enables standardized enrichment and enumeration
of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive “liquid …
of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive “liquid …
DNA damage response and resistance of cancer stem cells
The cancer stem cell (CSC) model defines tumors as hierarchically organized entities,
containing a small population of tumorigenic CSC, or tumour-initiating cells, placed at the …
containing a small population of tumorigenic CSC, or tumour-initiating cells, placed at the …
Microfluidic technologies for circulating tumor cell isolation
Metastasis is the main cause of tumor-related death, and the dispersal of tumor cells through
the circulatory system is a critical step in the metastatic process. Early detection and analysis …
the circulatory system is a critical step in the metastatic process. Early detection and analysis …
Functional implications of the dynamic regulation of EpCAM during epithelial-to-mesenchymal transition
TC Brown, NV Sankpal, WE Gillanders - Biomolecules, 2021 - mdpi.com
Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein expressed in
epithelial tissues. EpCAM forms intercellular, homophilic adhesions, modulates epithelial …
epithelial tissues. EpCAM forms intercellular, homophilic adhesions, modulates epithelial …
[HTML][HTML] EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
I Chebouti, S Kasimir-Bauer, P Buderath… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Assuming that tumor cell dissemination requires a shift to a mesenchymal
phenotype, we analyzed the incidence of epithelial-to-mesenchymal-transition (EMT)-like …
phenotype, we analyzed the incidence of epithelial-to-mesenchymal-transition (EMT)-like …
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer …
(1) Background: The aim of the study was to evaluate the prognostic significance of EMT-
associated (TWIST1) and stem-cell (SC) transcript (CD24, CD44, ALDH1) quantification in …
associated (TWIST1) and stem-cell (SC) transcript (CD24, CD44, ALDH1) quantification in …
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients
BACKGROUND Liquid biopsies are discussed to provide surrogate markers for therapy
stratification and monitoring. We compared messenger RNA (mRNA) profiles of circulating …
stratification and monitoring. We compared messenger RNA (mRNA) profiles of circulating …
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancer
M Bredemeier, P Edimiris, P Mach, M Kubista… - Clinical …, 2017 - academic.oup.com
BACKGROUND Circulating tumor cells (CTCs) are thought to be an ideal surrogate marker
to monitor disease progression in metastatic breast cancer (MBC). We investigated the …
to monitor disease progression in metastatic breast cancer (MBC). We investigated the …
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic …
I Chebouti, JD Kuhlmann, P Buderath, S Weber… - …, 2016 - pmc.ncbi.nlm.nih.gov
Background We recently showed that the presence of ERCC1+ CTCs is an independent
predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal …
predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal …